Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof.

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

Dermatology company Galderma may be best known for its moisturizer Cetaphil — but it’s taking on a new marketing challenge by bringing attention to its atopic dermatitis drug Nemluvio. On Tuesday ...

Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their ...

Differin's 'Level Up' campaign is integrated into top Roblox games. By infusing acne care into Roblox, Differin is tackling a significant emotional and mental health challenge with education ...

Shareholders of Galderma Group AG raised about 1.34 billion Swiss francs ($1.5 billion) from the sale of a roughly 6.3% stake in the Swiss skincare group. Buyout group EQT AB, Abu Dhabi Investment ...

Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof.

"The transaction is expected to increase the free float of Galderma and improve the liquidity of the stock," a spokesperson for the company said. "No changes to Galderma's governance and board ...

As for governance, Galderma said in a separate press release that no changes to the company’s board of directors are planned at this time. Galderma CEO Flemming Ørnskov, MD, MPH welcomed L’Oréal as a ...

for both frown lines and crow’s feet 3-8 Galderma is committed to developing and delivering the broadest portfolio in Injectable Aesthetics Once national approvals have taken place, Relfydess TM ...

As of December 2023, Galderma owned approximately 240 patent families and 2,100 patents and patent applications around the world, although no single patent is of material importance to the business.